FDA-rejected Merck med gets E.U. approval

Merck's cholesterol drug Tredaptive received approval in the European Union, Iceland, and Norway, clearing the way for marketing in 29 nations; formerly known as Cordaptive, it was rejected by the FDA earlier this year. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.